CIK 0001660334 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 35.6 M | |||
| Net income (USD) | -24.5 M | -35.1 M | ||
| Diluted EPS (USD/shares) | -1.68 | -1.48 | -0.72 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-18 | 4 | 4 | 2026-08-17 |
| 2026-08-18 | 4 | 4 | 2026-08-14 |
| 2026-08-18 | 4 | 4 | 2026-08-17 |
| 2026-08-18 | 4 | 4 | 2026-08-18 |
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-06 | 8-K | 8-K items 2.02,9.01 | 2026-08-06 |
| 2026-06-09 | 4 | 4 | 2026-06-05 |
| 2026-06-09 | 4 | 4 | 2026-06-05 |
| 2026-06-09 | 4 | 4 | 2026-06-05 |
| 2026-06-09 | 4 | 4 | 2026-06-05 |
| 2026-06-09 | 4 | 4 | 2026-06-05 |
| 2026-06-09 | 4 | 4 | 2026-06-05 |
| 2026-06-09 | 4 | 4 | 2026-06-05 |
| 2026-06-09 | 8-K | 8-K items 5.02,5.07,9.01 | 2026-06-05 |
| 2026-05-12 | S-8 | S-8 | |
| 2026-05-12 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-12 | 8-K | 8-K items 2.02,9.01 | 2026-05-12 |
| 2026-04-20 | ARS | ARS | 2025-12-31 |
| 2026-04-20 | DEFA14A | DEFA14A | |
| 2026-04-20 | DEF 14A | DEF 14A | 2026-06-05 |
| 2026-03-11 | 10-K | 10-K | 2025-12-31 |
| 2026-03-11 | 8-K | 8-K items 2.02,9.01 | 2026-03-11 |
| 2026-02-17 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-02-02 | 3/A | 3/A | 2025-11-25 |
| 2026-01-29 | SCHEDULE 13G/A | SCHEDULE 13G/A |
Forms on file (last 1,000): 4 215, 8-K 110, 3 26, 10-Q 25, 144 18, SC 13G/A 16, S-8 11, 4/A 10. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=VRCA (0.002 USD), /gw/filings/filings?ticker=VRCA&form=8-K, /gw/filings/facts?ticker=VRCA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange